Figure 1.
M protein–associated platelet-activating anti-PF4 disorder pathophysiology and clinical characteristics. BTK, Bruton tyrosine kinase; Ig, immunoglobulin; IVIG, IV immunoglobulin.
M protein–associated platelet-activating anti-PF4 disorder pathophysiology and clinical characteristics. BTK, Bruton tyrosine kinase; Ig, immunoglobulin; IVIG, IV immunoglobulin.
